CraigThomasCurtisMD

Research • Kissimmee, FL

Chief Medical Officer Compass Research/Bioclinica

Join to view full profile

Dr. Curtis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Curtis' full profile

Already have an account?

Office
700 W Oak St
Kissimmee, FL 34741
Phone+1 800-893-9698

Education & Training

St Vincent's Medical CenterResidency, Family Medicine, 2000 - 2002
Emory University School of MedicineResidency, Radiation Oncology, 1997 - 1998
AdventHealth FloridaInternship, Transitional Year, 1996 - 1997
Northeast Ohio Medical UniversityClass of 1996

Certifications & Licensure

FL State Medical License 1999 - 2026
National Board of Physicians and Surgeons Family Medicine

Clinical Trials

An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease Start of enrollment: 2009 Nov 01
Completed
Phase 1
The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Completed
Phase 2, Phase 3
A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects Start of enrollment: 2014 Aug 01
Completed
Phase 1
18F-AV-1451 Autopsy Study Start of enrollment: 2015 Sep 01
Completed
Phase 3
A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD Start of enrollment: 2015 Dec 22
Completed
Phase 1
A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Start of enrollment: 2017 Jan 31
Completed
Phase 1
Join now to see all